Skip to main

Proterra

PTRA is nowPTRAQ
PTRA logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More
Go to the new stock page

Frequently Asked Questions (FAQ)

As of Jun 12, 2025, the market cap for Proterra stock is $588.9K

The current P/E ratio for Proterra stock is -0.25

The 52-week high for Proterra stock is $0.00. The current Proterra stock price $undefined is 100.00% below its 52-week high

No, the Proterra stock does not pay dividends to its shareholders

How to buy Proterra stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Proterra stock

    Navigate to the Explore page. Then, type Proterra into the search bar. When you see Proterra stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Proterra stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Proterra Stock Earnings

The value each PTRA share was expected to gain vs. the value that each PTRA share actually gained.

Proterra (PTRA) reported Q3 2023 earnings per share (EPS) of -$0.33, missing estimates of -$0.19 by 73.68%. In the same quarter last year, Proterra's earnings per share (EPS) was -$0.45. Proterra is expected to release next earnings on 12/31/2024, with an earnings per share (EPS) estimate of $0.

Buy Proterra (PTRA) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.